HALF YEARLY RESULTS
Zydus Lifesciences Ltd.
BSE
May 02
885.45
-2.25 ( -0.25%)
Volume
11464
Prev. Close
887.70
Open Price
890.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
May 02
885.60
-2.65 ( -0.30%)
Volume
803068
Prev. Close
888.25
Open Price
887.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Halfyearly Results
for the last 5 years.
ISIN No
|
INE010B01027
|
Market Cap. ( ₹ in Cr. )
|
89112.08
|
P/BV
|
4.08
|
Book Value ( ₹ )
|
216.89
|
BSE Code
|
532321
|
52 Week High/Low ( ₹ )
|
1324/795
|
FV/ML
|
1/1
|
P/E(X)
|
23.09
|
NSE Code
|
ZYDUSLIFEEQ
|
Book Closure
|
26/07/2024
|
EPS ( ₹ )
|
38.36
|
Div Yield (%)
|
0.34
|
(₹ in Crs.)
Net Sales/Income from operations | 6547.70 | 5543.90 | 5115.00 | 4524.20 | 4053.20 |
Other Operating Income | 233.10 | 159.80 | 0.00 | 142.00 | 326.50 |
Total Income From Operations | 6780.80 | 5703.70 | 5115.00 | 4666.20 | 4379.70 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 1430.50 | 1418.80 | 1582.60 | 1432.80 | 1270.70 |
Purchase of Traded Goods | 145.80 | 139.80 | 143.40 | 155.80 | 206.90 |
Increase/Decrease in Stocks | -185.30 | -61.70 | -70.00 | 24.00 | 81.10 |
Employees Cost | 860.90 | 778.10 | 729.40 | 679.20 | 642.70 |
Depreciation | 264.30 | 258.30 | 246.10 | 241.50 | 247.10 |
Other Expenses | 1213.80 | 1160.40 | 939.20 | 1143.30 | 955.00 |
Total Expenses | 3730.00 | 3693.70 | 3570.70 | 3676.60 | 3403.50 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 3050.80 | 2010.00 | 1544.30 | 989.60 | 976.20 |
Other Income | 433.30 | 467.90 | 616.90 | 387.50 | 160.90 |
P/L Before Interest, Excpt. Items & Tax | 3484.10 | 2477.90 | 2161.20 | 1377.10 | 1137.10 |
Interest | 211.30 | 210.10 | 180.60 | 173.50 | 104.70 |
P/L Before Exceptional Items & Tax | 3272.80 | 2267.80 | 1980.60 | 1203.60 | 1032.40 |
Exceptional Items | 0.00 | -8.60 | 0.00 | -203.80 | 0.00 |
P/L Before Tax | 3272.80 | 2259.20 | 1980.60 | 999.80 | 1032.40 |
Tax | 782.20 | 403.60 | 394.70 | 253.20 | 249.80 |
P/L After Tax from Ordinary Activities | 2490.60 | 1855.60 | 1585.90 | 746.60 | 782.60 |
Net Profit/Loss For the Period | 2490.60 | 1855.60 | 1585.90 | 746.60 | 782.60 |
| | | | | |
Equity Share Capital | 100.60 | 100.60 | 101.20 | 101.20 | 101.20 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 24.75 | 18.45 | 15.67 | 7.38 | 7.68 |
Diluted EPS (Rs.) | 24.75 | 18.45 | 15.67 | 7.38 | 7.68 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 24.75 | 18.45 | 15.67 | 7.38 | 7.73 |
Diluted EPS (Rs.) | 24.75 | 0.00 | 15.67 | 0.00 | 7.68 |
| | | | | |
PBITOE Margin (%) | 44.99 | 35.24 | 30.19 | 21.20 | 22.28 |
PBTE Margin (%) | 48.26 | 39.76 | 38.72 | 25.79 | 23.57 |
PBT Margin (%) | 48.26 | 39.60 | 38.72 | 21.42 | 23.57 |
PAT Margin (%) | 36.73 | 32.53 | 31.00 | 16.00 | 17.86 |